US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

4.45

0.0000

Post-market: 4.450.00000.00%19:42 EST

Volume:29.89K

Turnover:136.15K

Market Cap:32.09M

PE:2.03

High:4.68

Open:4.45

Low:4.45

Close:4.45

52wk High:19.15

52wk Low:4.20

Shares:7.21M

Float Shares:4.61M

Volume Ratio:0.35

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.19

EPS(LYR):-11.4053

ROE:-2014.86%

ROA:30.86%

PB:-0.88

PE(LYR):-0.39

Loading ...

Overview Company News Filings

Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics

Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc

Atara's Outlook As Ebvallo Hits Second FDA CRL

Benzinga_recent_news

Atara Biotherapeutics Cut to Hold From Buy by Canaccord Genuity

Canaccord Genuity Downgrades Atara Biotherapeutics to Hold From Buy, Adjusts PT to $6 From $25

MT Newswires Live

Top Midday Decliners

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners

Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo

Atara Biotherapeutics Shares Plunge 55% Premarket After US FDA Declines to Approve Co's Blood Cancer Therapy

THOMSON REUTERS

FDA says unable to approve Atara Biotherapeutics Ebvallo BLA in present form

BUZZ-Atara Biotherapeutics sinks as FDA rejects cancer drug application

BRIEF-Pierre Fabre Pharmaceuticals On Jan 9, Got Complete Response Letter For Tabelecleucel BLA From U.S. FDA

Pierre Fabre: in New Crl, FDA Said It No Longer Considers Previously Accepted Single-Arm Allele Study to Be Enough to Support Accelerated Approval

THOMSON REUTERS

US FDA declines to approve Atara's therapy for rare blood cancer

BRIEF-Atara Biotherapeutics Provides Regulatory And Business Update On Ebvallo™ (Tabelecleucel)

Atara Biotherapeutics Slashes Workforce by 90 Percent

Atara Biotherapeutics Inc - FDA Unable to Approve Ebvallo Bla in Present Form

THOMSON REUTERS

Atara Biotherapeutics Inc - FDA Issues Complete Response Letter for Ebvallo Bla

THOMSON REUTERS

Atara Biotherapeutics Inc: U.S. Food and Drug Administration Has Issued a Complete Response Letter (Crl)

THOMSON REUTERS

Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo™ (Tabelecleucel)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATRA\",,,,,undefined,":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":4.45,"timestamp":1771016400000,"preClose":4.45,"halted":0,"volume":29890,"hourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.45,"latestTime":"19:42 EST","volume":72,"amount":324.7169,"timestamp":1771029762073,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":4609000,"shares":7210235,"eps":2.194,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:00:00 EST","open":4.45,"high":4.6799,"low":4.45,"amount":136146.45119599998,"amplitude":0.051663,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.194,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1413432000000,"exchange":"NASDAQ","adjPreClose":4.45,"preHourTrading":{"tag":"盘前","latestPrice":4.3172,"preClose":4.45,"latestTime":"08:00 EST","volume":1,"amount":4.3172,"timestamp":1770987604945,"change":-0.1328,"changeRate":-0.029843,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.45,"latestTime":"19:42 EST","volume":72,"amount":324.7169,"timestamp":1771029762073,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.34749833785900625,"impliedVol":0.0156,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATRA\",,,,,undefined,":{"symbol":"ATRA","floatShares":4609000,"roa":"30.86%","roe":"-2014.86%","lyrEps":-11.405315,"volumeRatio":0.34749833785900625,"shares":7210235,"dividePrice":0,"high":4.6799,"amplitude":0.051663,"preClose":4.45,"low":4.45,"week52Low":4.2,"pbRate":"-0.88","psRate":"0.21","week52High":19.145,"institutionHeld":0,"latestPrice":4.45,"eps":2.194,"divideRate":0,"volume":29890,"delay":0,"ttmEps":2.194,"open":4.45,"prevYearClose":18.09,"prevWeekClose":4.88,"prevMonthClose":5.2,"prevQuarterClose":18.09,"fiveDayClose":4.88,"twentyDayClose":4.62,"sixtyDayClose":13.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ATRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-08-11","symbol":"ATRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":0.19},{"market":"US","date":"2025-05-15","symbol":"ATRA","fiscalQuarterEnding":"2025/03","expectedEps":-3.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":3.5},{"market":"US","date":"2025-03-07","symbol":"ATRA","fiscalQuarterEnding":"2024/12","expectedEps":-3.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741323600000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2024-11-12","symbol":"ATRA","fiscalQuarterEnding":"2024/09","expectedEps":-3.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.5,"sell":0.25,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":4,"updateTime":1769058000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATRA","date":"2026-02-13","current":2.028259,"percent":0.897876,"low":-5.656868,"twenty":-3.617614,"median":-1.002656,"eighty":-0.245698,"high":28.522215,"avg":-0.532371,"sd":4.617075,"marketCap":32085545},"quantilePoints":[{"date":"2021-02-19","current":-4.873971,"twenty":-13.392279,"median":-7.191804,"eighty":-3.157132,"marketCap":1480756212},{"date":"2021-02-26","current":-4.574118,"twenty":-13.199069,"median":-7.149529,"eighty":-3.157132,"marketCap":1389658235},{"date":"2021-03-05","current":-4.382267,"twenty":-13.139307,"median":-7.094622,"eighty":-3.1569,"marketCap":1343690687},{"date":"2021-03-12","current":-4.608607,"twenty":-13.056844,"median":-6.97602,"eighty":-3.1569,"marketCap":1413091015},{"date":"2021-03-19","current":-4.101387,"twenty":-12.95938,"median":-6.943288,"eighty":-3.1569,"marketCap":1257567389},{"date":"2021-03-26","current":-4.03594,"twenty":-12.882467,"median":-6.914441,"eighty":-3.157132,"marketCap":1237499824},{"date":"2021-04-01","current":-4.065937,"twenty":-12.85666,"median":-6.88488,"eighty":-3.157132,"marketCap":1246697458},{"date":"2021-04-09","current":-3.75506,"twenty":-12.742945,"median":-6.869396,"eighty":-3.1569,"marketCap":1151376525},{"date":"2021-04-16","current":-3.621438,"twenty":-12.643743,"median":-6.824351,"eighty":-3.1569,"marketCap":1110405247},{"date":"2021-04-23","current":-3.877259,"twenty":-12.554952,"median":-6.784507,"eighty":-3.1569,"marketCap":1188845061},{"date":"2021-04-30","current":-3.855322,"twenty":-12.506885,"median":-6.753144,"eighty":-3.1569,"marketCap":1182118922},{"date":"2021-05-07","current":-3.668703,"twenty":-12.332491,"median":-6.734261,"eighty":-3.1569,"marketCap":1142602855},{"date":"2021-05-14","current":-4.046641,"twenty":-12.201936,"median":-6.711738,"eighty":-3.1569,"marketCap":1260310287},{"date":"2021-05-21","current":-3.717295,"twenty":-12.04167,"median":-6.701173,"eighty":-3.1569,"marketCap":1157736668},{"date":"2021-05-28","current":-3.660604,"twenty":-11.945762,"median":-6.663994,"eighty":-3.1569,"marketCap":1140080553},{"date":"2021-06-04","current":-3.558021,"twenty":-11.860844,"median":-6.64417,"eighty":-3.1569,"marketCap":1108131393},{"date":"2021-06-11","current":-3.887367,"twenty":-11.734357,"median":-6.597131,"eighty":-3.1569,"marketCap":1210705012},{"date":"2021-06-18","current":-4.052041,"twenty":-11.65961,"median":-6.574843,"eighty":-3.1569,"marketCap":1261991822},{"date":"2021-06-25","current":-4.413782,"twenty":-11.620814,"median":-6.547695,"eighty":-3.1569,"marketCap":1374654649},{"date":"2021-07-02","current":-4.297701,"twenty":-11.573858,"median":-6.50798,"eighty":-3.1569,"marketCap":1338501653},{"date":"2021-07-09","current":-3.819878,"twenty":-11.523867,"median":-6.486512,"eighty":-3.1569,"marketCap":1189685828},{"date":"2021-07-16","current":-3.579617,"twenty":-11.435141,"median":-6.463405,"eighty":-3.1569,"marketCap":1114857532},{"date":"2021-07-23","current":-3.447339,"twenty":-11.392427,"median":-6.418944,"eighty":-3.1569,"marketCap":1073659931},{"date":"2021-07-30","current":-3.44194,"twenty":-11.358954,"median":-6.396421,"eighty":-3.1569,"marketCap":1071978396},{"date":"2021-08-06","current":-3.412245,"twenty":-11.202892,"median":-6.351967,"eighty":-3.1569,"marketCap":1062729955},{"date":"2021-08-13","current":-3.320604,"twenty":-11.111326,"median":-6.306331,"eighty":-3.1569,"marketCap":1055231509},{"date":"2021-08-20","current":-3.368613,"twenty":-10.950561,"median":-6.285104,"eighty":-3.1569,"marketCap":1070487869},{"date":"2021-08-27","current":-3.920713,"twenty":-10.869994,"median":-6.133353,"eighty":-3.1569,"marketCap":1245935999},{"date":"2021-09-03","current":-4.150088,"twenty":-10.808757,"median":-6.084516,"eighty":-3.1569,"marketCap":1318827493},{"date":"2021-09-10","current":-4.182094,"twenty":-10.771656,"median":-6.058582,"eighty":-3.1569,"marketCap":1328998399},{"date":"2021-09-17","current":-4.28878,"twenty":-10.72894,"median":-6.026645,"eighty":-3.1569,"marketCap":1362901420},{"date":"2021-09-24","current":-4.534158,"twenty":-10.669988,"median":-5.968492,"eighty":-3.1569,"marketCap":1440878367},{"date":"2021-10-01","current":-4.667516,"twenty":-10.577989,"median":-5.929441,"eighty":-3.1569,"marketCap":1483257142},{"date":"2021-10-08","current":-4.547494,"twenty":-10.545918,"median":-5.900924,"eighty":-3.1569,"marketCap":1445116244},{"date":"2021-10-15","current":-4.032734,"twenty":-10.489134,"median":-5.768077,"eighty":-3.1569,"marketCap":1281534171},{"date":"2021-10-22","current":-4.275444,"twenty":-10.423167,"median":-5.72307,"eighty":-3.1569,"marketCap":1358663542},{"date":"2021-10-29","current":-4.128751,"twenty":-10.423167,"median":-5.648136,"eighty":-3.1569,"marketCap":1312046889},{"date":"2021-11-05","current":-4.896522,"twenty":-10.423167,"median":-5.552729,"eighty":-3.1569,"marketCap":1606543903},{"date":"2021-11-12","current":-4.748306,"twenty":-10.393396,"median":-5.480725,"eighty":-3.1569,"marketCap":1557914341},{"date":"2021-11-19","current":-4.931555,"twenty":-10.312261,"median":-5.443441,"eighty":-3.1569,"marketCap":1618038163},{"date":"2021-11-26","current":-4.734831,"twenty":-10.248252,"median":-5.423247,"eighty":-3.1569,"marketCap":1553493472},{"date":"2021-12-03","current":-4.605479,"twenty":-10.167865,"median":-5.406157,"eighty":-3.1569,"marketCap":1511053126},{"date":"2021-12-10","current":-4.306352,"twenty":-10.114867,"median":-5.351009,"eighty":-3.1569,"marketCap":1412909828},{"date":"2021-12-17","current":-4.082681,"twenty":-10.070909,"median":-5.312947,"eighty":-3.1569,"marketCap":1339523397},{"date":"2021-12-23","current":-4.664766,"twenty":-10.000377,"median":-5.275664,"eighty":-3.1569,"marketCap":1530504951},{"date":"2021-12-31","current":-4.247066,"twenty":-10.000377,"median":-5.219738,"eighty":-3.1569,"marketCap":1393458003},{"date":"2022-01-07","current":-4.233591,"twenty":-9.989866,"median":-5.175187,"eighty":-3.157132,"marketCap":1389037134},{"date":"2022-01-14","current":-4.330606,"twenty":-9.961007,"median":-5.113595,"eighty":-3.157132,"marketCap":1420867393},{"date":"2022-01-21","current":-3.770079,"twenty":-9.961007,"median":-5.071783,"eighty":-3.157132,"marketCap":1236959230},{"date":"2022-01-28","current":-4.00453,"twenty":-9.961007,"median":-5.02065,"eighty":-3.157132,"marketCap":1313882355},{"date":"2022-02-04","current":-3.937159,"twenty":-9.961007,"median":-4.985734,"eighty":-3.157132,"marketCap":1291778009},{"date":"2022-02-11","current":-3.923685,"twenty":-9.933161,"median":-4.899216,"eighty":-3.157132,"marketCap":1287357140},{"date":"2022-02-18","current":-3.535628,"twenty":-9.927271,"median":-4.85142,"eighty":-3.157132,"marketCap":1160036104},{"date":"2022-02-25","current":-3.554492,"twenty":-9.927271,"median":-4.812982,"eighty":-3.157132,"marketCap":1166225321},{"date":"2022-03-04","current":-2.422273,"twenty":-9.860817,"median":-4.763948,"eighty":-3.145245,"marketCap":823914459},{"date":"2022-03-11","current":-2.468803,"twenty":-9.73795,"median":-4.724052,"eighty":-3.133131,"marketCap":839741064},{"date":"2022-03-18","current":-2.679554,"twenty":-9.667125,"median":-4.687497,"eighty":-3.109901,"marketCap":911426277},{"date":"2022-03-25","current":-2.57281,"twenty":-9.496312,"median":-4.664638,"eighty":-3.078143,"marketCap":875118182},{"date":"2022-04-01","current":-2.60018,"twenty":-9.41974,"median":-4.650041,"eighty":-3.058063,"marketCap":884427950},{"date":"2022-04-08","current":-2.39764,"twenty":-9.353968,"median":-4.632345,"eighty":-3.037531,"marketCap":815535668},{"date":"2022-04-14","current":-2.192363,"twenty":-9.235675,"median":-4.615216,"eighty":-3.013211,"marketCap":745712408},{"date":"2022-04-22","current":-1.987085,"twenty":-9.061426,"median":-4.585788,"eighty":-2.977344,"marketCap":675889149},{"date":"2022-04-29","current":-1.746512,"twenty":-8.896503,"median":-4.549538,"eighty":-2.960311,"marketCap":594060417},{"date":"2022-05-06","current":-1.847234,"twenty":-8.821896,"median":-4.512962,"eighty":-2.938752,"marketCap":646367623},{"date":"2022-05-13","current":-1.462839,"twenty":-8.821896,"median":-4.472701,"eighty":-2.903427,"marketCap":511863378},{"date":"2022-05-20","current":-1.377418,"twenty":-8.821896,"median":-4.404765,"eighty":-2.878693,"marketCap":481973546},{"date":"2022-05-27","current":-1.390765,"twenty":-8.821896,"median":-4.383385,"eighty":-2.835056,"marketCap":486643832},{"date":"2022-06-03","current":-1.372079,"twenty":-8.821896,"median":-4.349289,"eighty":-2.792124,"marketCap":480105431},{"date":"2022-06-10","current":-1.393434,"twenty":-8.821896,"median":-4.331031,"eighty":-2.759282,"marketCap":487577889},{"date":"2022-06-17","current":-1.566946,"twenty":-8.821896,"median":-4.3029,"eighty":-2.720678,"marketCap":548291611},{"date":"2022-06-24","current":-1.951342,"twenty":-8.825822,"median":-4.279404,"eighty":-2.710028,"marketCap":682795857},{"date":"2022-07-01","current":-2.215613,"twenty":-8.825822,"median":-4.240771,"eighty":-2.699115,"marketCap":775267525},{"date":"2022-07-08","current":-2.269002,"twenty":-8.825822,"median":-4.23277,"eighty":-2.692806,"marketCap":793948671},{"date":"2022-07-15","current":-1.027724,"twenty":-8.825822,"median":-4.220117,"eighty":-2.681196,"marketCap":359612045},{"date":"2022-07-22","current":-0.859551,"twenty":-8.825822,"median":-4.202286,"eighty":-2.667105,"marketCap":300766437},{"date":"2022-07-29","current":-0.808832,"twenty":-8.825822,"median":-4.195117,"eighty":-2.649754,"marketCap":283019349},{"date":"2022-08-05","current":-0.918278,"twenty":-8.825822,"median":-4.182094,"eighty":-2.635005,"marketCap":321315697},{"date":"2022-08-12","current":-2.225203,"twenty":-8.825822,"median":-4.160831,"eighty":-2.626804,"marketCap":551075948},{"date":"2022-08-19","current":-1.695574,"twenty":-8.825822,"median":-4.129681,"eighty":-2.60747,"marketCap":419912324},{"date":"2022-08-26","current":-1.535542,"twenty":-8.825822,"median":-4.101544,"eighty":-2.597817,"marketCap":380280149},{"date":"2022-09-02","current":-1.63461,"twenty":-8.825822,"median":-4.083409,"eighty":-2.592697,"marketCap":404814352},{"date":"2022-09-09","current":-1.836554,"twenty":-8.825822,"median":-4.054071,"eighty":-2.58627,"marketCap":454826382},{"date":"2022-09-16","current":-1.539353,"twenty":-8.825822,"median":-4.046641,"eighty":-2.572757,"marketCap":381223772},{"date":"2022-09-23","current":-1.261202,"twenty":-8.825822,"median":-4.034173,"eighty":-2.562107,"marketCap":312339279},{"date":"2022-09-30","current":-1.440285,"twenty":-8.825822,"median":-4.02629,"eighty":-2.553014,"marketCap":356689569},{"date":"2022-10-07","current":-1.455527,"twenty":-8.825822,"median":-4.002781,"eighty":-2.545795,"marketCap":360464062},{"date":"2022-10-14","current":-1.421234,"twenty":-8.825822,"median":-3.995393,"eighty":-2.540489,"marketCap":351971453},{"date":"2022-10-21","current":-1.611748,"twenty":-8.825822,"median":-3.974887,"eighty":-2.529966,"marketCap":399152613},{"date":"2022-10-28","current":-1.840365,"twenty":-8.825822,"median":-3.97015,"eighty":-2.523716,"marketCap":455770005},{"date":"2022-11-04","current":-1.809882,"twenty":-8.825822,"median":-3.938659,"eighty":-2.510716,"marketCap":448221020},{"date":"2022-11-11","current":-1.969927,"twenty":-8.825822,"median":-3.923874,"eighty":-2.503848,"marketCap":486727577},{"date":"2022-11-18","current":-1.639686,"twenty":-8.825822,"median":-3.917063,"eighty":-2.481817,"marketCap":405131920},{"date":"2022-11-25","current":-1.605126,"twenty":-8.825822,"median":-3.887367,"eighty":-2.461589,"marketCap":396592840},{"date":"2022-12-02","current":-1.827846,"twenty":-8.825822,"median":-3.877774,"eighty":-2.44425,"marketCap":451622469},{"date":"2022-12-09","current":-1.708806,"twenty":-8.825822,"median":-3.869594,"eighty":-2.434311,"marketCap":422210081},{"date":"2022-12-16","current":-1.351685,"twenty":-8.825822,"median":-3.856314,"eighty":-2.416355,"marketCap":333972918},{"date":"2022-12-23","current":-1.148164,"twenty":-8.825822,"median":-3.841377,"eighty":-2.384785,"marketCap":283687223},{"date":"2022-12-30","current":-1.259524,"twenty":-8.825822,"median":-3.819878,"eighty":-2.361486,"marketCap":311202037},{"date":"2023-01-06","current":-1.344005,"twenty":-8.825822,"median":-3.795582,"eighty":-2.33702,"marketCap":332075345},{"date":"2023-01-13","current":-1.493765,"twenty":-8.806189,"median":-3.776876,"eighty":-2.31985,"marketCap":369078026},{"date":"2023-01-20","current":-1.493765,"twenty":-8.670225,"median":-3.755089,"eighty":-2.306771,"marketCap":369078026},{"date":"2023-01-27","current":-2.023687,"twenty":-8.527881,"median":-3.725394,"eighty":-2.249037,"marketCap":500010590},{"date":"2023-02-03","current":-1.985287,"twenty":-8.456709,"median":-3.706074,"eighty":-2.193457,"marketCap":490522723},{"date":"2023-02-10","current":-1.789944,"twenty":-8.325655,"median":-3.688814,"eighty":-2.164565,"marketCap":408647788},{"date":"2023-02-17","current":-1.899189,"twenty":-8.139454,"median":-3.676802,"eighty":-2.116898,"marketCap":433588733},{"date":"2023-02-24","current":-1.705909,"twenty":-7.980818,"median":-3.660604,"eighty":-2.097825,"marketCap":389462446},{"date":"2023-03-03","current":-1.51683,"twenty":-7.848516,"median":-3.644407,"eighty":-2.064257,"marketCap":346295426},{"date":"2023-03-10","current":-1.189094,"twenty":-7.749269,"median":-3.624165,"eighty":-2.023579,"marketCap":271472592},{"date":"2023-03-17","current":-1.268927,"twenty":-7.584484,"median":-3.613991,"eighty":-2.004345,"marketCap":289698667},{"date":"2023-03-24","current":-1.205901,"twenty":-7.424315,"median":-3.598514,"eighty":-1.981319,"marketCap":275309660},{"date":"2023-03-31","current":-1.218506,"twenty":-7.332537,"median":-3.576981,"eighty":-1.950996,"marketCap":278187461},{"date":"2023-04-06","current":-1.168086,"twenty":-7.250833,"median":-3.565524,"eighty":-1.931366,"marketCap":266676256},{"date":"2023-04-14","current":-1.147007,"twenty":-7.095359,"median":-3.554492,"eighty":-1.895669,"marketCap":261864077},{"date":"2023-04-21","current":-1.20203,"twenty":-6.843537,"median":-3.53085,"eighty":-1.881801,"marketCap":274425823},{"date":"2023-04-28","current":-1.091985,"twenty":-6.706248,"median":-3.504954,"eighty":-1.856762,"marketCap":249302332},{"date":"2023-05-05","current":-1.163937,"twenty":-6.56802,"median":-3.480711,"eighty":-1.840365,"marketCap":265729230},{"date":"2023-05-12","current":-1.033857,"twenty":-6.361412,"median":-3.454026,"eighty":-1.821747,"marketCap":222246265},{"date":"2023-05-19","current":-0.929736,"twenty":-6.139895,"median":-3.442088,"eighty":-1.815179,"marketCap":199863381},{"date":"2023-05-26","current":-0.875045,"twenty":-6.055923,"median":-3.422526,"eighty":-1.807132,"marketCap":188106712},{"date":"2023-06-02","current":-0.683629,"twenty":-5.972415,"median":-3.417493,"eighty":-1.796408,"marketCap":146958369},{"date":"2023-06-09","current":-0.856815,"twenty":-5.879816,"median":-3.396668,"eighty":-1.789676,"marketCap":184187822},{"date":"2023-06-16","current":-0.975311,"twenty":-5.581624,"median":-3.381734,"eighty":-1.783976,"marketCap":209660606},{"date":"2023-06-23","current":-0.79301,"twenty":-5.465771,"median":-3.368613,"eighty":-1.772542,"marketCap":170471708},{"date":"2023-06-30","current":-0.742877,"twenty":-5.351009,"median":-3.348699,"eighty":-1.754886,"marketCap":159694760},{"date":"2023-07-07","current":-0.756549,"twenty":-5.280135,"median":-3.341338,"eighty":-1.745214,"marketCap":162633928},{"date":"2023-07-14","current":-0.906948,"twenty":-5.218317,"median":-3.322513,"eighty":-1.737487,"marketCap":194964769},{"date":"2023-07-21","current":-0.943408,"twenty":-5.142475,"median":-3.317713,"eighty":-1.721059,"marketCap":202802549},{"date":"2023-07-28","current":-0.815797,"twenty":-5.072964,"median":-3.285578,"eighty":-1.708806,"marketCap":175370320},{"date":"2023-08-04","current":-1.052789,"twenty":-4.996638,"median":-3.251137,"eighty":-1.69489,"marketCap":226315888},{"date":"2023-08-11","current":-0.723719,"twenty":-4.931555,"median":-3.200735,"eighty":-1.674761,"marketCap":220402691},{"date":"2023-08-18","current":-0.53117,"twenty":-4.869573,"median":-3.195657,"eighty":-1.654632,"marketCap":161763443},{"date":"2023-08-25","current":-0.497971,"twenty":-4.821066,"median":-3.183328,"eighty":-1.639686,"marketCap":151653228},{"date":"2023-09-01","current":-0.484692,"twenty":-4.774202,"median":-3.151745,"eighty":-1.611748,"marketCap":147609141},{"date":"2023-09-08","current":-0.511251,"twenty":-4.729496,"median":-3.140344,"eighty":-1.607938,"marketCap":155697314},{"date":"2023-09-15","current":-0.507931,"twenty":-4.699522,"median":-3.124149,"eighty":-1.601286,"marketCap":154686292},{"date":"2023-09-22","current":-0.590926,"twenty":-4.67395,"median":-3.108419,"eighty":-1.593316,"marketCap":179961830},{"date":"2023-09-28","current":-0.504611,"twenty":-4.662137,"median":-3.078971,"eighty":-1.580843,"marketCap":153675271},{"date":"2023-10-06","current":-0.464773,"twenty":-4.639244,"median":-3.059334,"eighty":-1.569081,"marketCap":141543012},{"date":"2023-10-13","current":-0.501291,"twenty":-4.617653,"median":-3.042406,"eighty":-1.547838,"marketCap":152664249},{"date":"2023-10-20","current":-0.458134,"twenty":-4.601168,"median":-3.012055,"eighty":-1.527719,"marketCap":139520969},{"date":"2023-10-27","current":-0.444855,"twenty":-4.570108,"median":-2.997338,"eighty":-1.520301,"marketCap":135476883},{"date":"2023-11-03","current":-0.417875,"twenty":-4.529813,"median":-2.962163,"eighty":-1.513558,"marketCap":121287477},{"date":"2023-11-10","current":-0.084277,"twenty":-4.495251,"median":-2.940426,"eighty":-1.493765,"marketCap":24461340},{"date":"2023-11-17","current":-0.16873,"twenty":-4.413478,"median":-2.921482,"eighty":-1.481669,"marketCap":48973641},{"date":"2023-11-24","current":-0.228848,"twenty":-4.393647,"median":-2.888721,"eighty":-1.456989,"marketCap":66422730},{"date":"2023-12-01","current":-0.231763,"twenty":-4.379093,"median":-2.842011,"eighty":-1.44254,"marketCap":67268685},{"date":"2023-12-08","current":-0.244018,"twenty":-4.33972,"median":-2.814054,"eighty":-1.411487,"marketCap":70825771},{"date":"2023-12-15","current":-0.240331,"twenty":-4.325987,"median":-2.769832,"eighty":-1.390757,"marketCap":69755587},{"date":"2023-12-22","current":-0.15658,"twenty":-4.294133,"median":-2.726844,"eighty":-1.383131,"marketCap":45447131},{"date":"2023-12-29","current":-0.192609,"twenty":-4.272034,"median":-2.715933,"eighty":-1.377418,"marketCap":55904354},{"date":"2024-01-05","current":-0.158406,"twenty":-4.240771,"median":-2.709477,"eighty":-1.372079,"marketCap":45977126},{"date":"2024-01-12","current":-0.211642,"twenty":-4.228202,"median":-2.697965,"eighty":-1.353393,"marketCap":61428540},{"date":"2024-01-19","current":-0.256344,"twenty":-4.217437,"median":-2.687765,"eighty":-1.344005,"marketCap":74403242},{"date":"2024-01-26","current":-0.211782,"twenty":-4.202286,"median":-2.67941,"eighty":-1.329368,"marketCap":61469308},{"date":"2024-02-02","current":-0.291459,"twenty":-4.195117,"median":-2.660859,"eighty":-1.300005,"marketCap":84595467},{"date":"2024-02-09","current":-0.29002,"twenty":-4.182094,"median":-2.646508,"eighty":-1.291685,"marketCap":84177586},{"date":"2024-02-16","current":-0.270917,"twenty":-4.160831,"median":-2.632972,"eighty":-1.282447,"marketCap":78633015},{"date":"2024-02-23","current":-0.276395,"twenty":-4.139272,"median":-2.625813,"eighty":-1.268823,"marketCap":80223002},{"date":"2024-03-01","current":-0.273199,"twenty":-4.113941,"median":-2.609292,"eighty":-1.259524,"marketCap":79295510},{"date":"2024-03-08","current":-0.24451,"twenty":-4.096871,"median":-2.599298,"eighty":-1.248726,"marketCap":70968462},{"date":"2024-03-15","current":-0.221228,"twenty":-4.063564,"median":-2.592911,"eighty":-1.231854,"marketCap":64211017},{"date":"2024-03-22","current":-0.234923,"twenty":-4.047811,"median":-2.586167,"eighty":-1.205901,"marketCap":68185985},{"date":"2024-03-28","current":-0.258381,"twenty":-4.035832,"median":-2.57281,"eighty":-1.201699,"marketCap":71345575},{"date":"2024-04-05","current":-0.33669,"twenty":-4.026348,"median":-2.562067,"eighty":-1.172402,"marketCap":92968904},{"date":"2024-04-12","current":-0.308118,"twenty":-4.00453,"median":-2.553014,"eighty":-1.148164,"marketCap":85079259},{"date":"2024-04-19","current":-0.298997,"twenty":-3.995393,"median":-2.545736,"eighty":-1.142775,"marketCap":82560779},{"date":"2024-04-26","current":-0.302498,"twenty":-3.979799,"median":-2.542703,"eighty":-1.092047,"marketCap":83527589},{"date":"2024-05-03","current":-0.28359,"twenty":-3.973022,"median":-2.529966,"eighty":-1.040368,"marketCap":78306614},{"date":"2024-05-10","current":-0.281944,"twenty":-3.954644,"median":-2.525166,"eighty":-1.003567,"marketCap":65723128},{"date":"2024-05-17","current":-0.311802,"twenty":-3.930191,"median":-2.512284,"eighty":-0.982603,"marketCap":72683180},{"date":"2024-05-24","current":-0.335771,"twenty":-3.920713,"median":-2.504396,"eighty":-0.96729,"marketCap":78270489},{"date":"2024-05-31","current":-0.293515,"twenty":-3.909748,"median":-2.495593,"eighty":-0.957081,"marketCap":68420449},{"date":"2024-06-07","current":-0.29398,"twenty":-3.87899,"median":-2.463329,"eighty":-0.947966,"marketCap":68528824},{"date":"2024-06-14","current":-0.272491,"twenty":-3.87387,"median":-2.445213,"eighty":-0.934293,"marketCap":63519512},{"date":"2024-06-21","current":-0.183899,"twenty":-3.859231,"median":-2.440081,"eighty":-0.91424,"marketCap":42868140},{"date":"2024-06-28","current":-0.170675,"twenty":-3.857155,"median":-2.426207,"eighty":-0.902288,"marketCap":39785487},{"date":"2024-07-05","current":-0.15931,"twenty":-3.857155,"median":-2.411385,"eighty":-0.87778,"marketCap":37136332},{"date":"2024-07-12","current":-0.209727,"twenty":-3.857155,"median":-2.378874,"eighty":-0.870488,"marketCap":48888946},{"date":"2024-07-15","current":-0.21634,"twenty":-3.857155,"median":-2.374538,"eighty":-0.866842,"marketCap":50430273},{"date":"2024-08-02","current":-0.214893,"twenty":-3.869127,"median":-2.330398,"eighty":-0.847806,"marketCap":50093108},{"date":"2024-08-09","current":-0.158484,"twenty":-3.869127,"median":-2.311712,"eighty":-0.826735,"marketCap":36943667},{"date":"2024-08-16","current":-0.185419,"twenty":-3.869127,"median":-2.274615,"eighty":-0.792932,"marketCap":33569784},{"date":"2024-08-23","current":-0.193292,"twenty":-3.869127,"median":-2.225203,"eighty":-0.759089,"marketCap":34995148},{"date":"2024-08-30","current":-0.191663,"twenty":-3.869127,"median":-2.188256,"eighty":-0.735098,"marketCap":34700245},{"date":"2024-09-06","current":-0.271478,"twenty":-3.869127,"median":-2.145911,"eighty":-0.718621,"marketCap":49150490},{"date":"2024-09-13","current":-0.219354,"twenty":-3.869127,"median":-2.115116,"eighty":-0.671779,"marketCap":39713595},{"date":"2024-09-20","current":-0.248522,"twenty":-3.869127,"median":-2.079473,"eighty":-0.585614,"marketCap":44994415},{"date":"2024-09-27","current":-0.24006,"twenty":-3.869127,"median":-2.034689,"eighty":-0.537145,"marketCap":43462449},{"date":"2024-10-04","current":-0.225644,"twenty":-3.869127,"median":-2.007391,"eighty":-0.519882,"marketCap":40852432},{"date":"2024-10-11","current":-0.243821,"twenty":-3.869127,"median":-1.989127,"eighty":-0.509923,"marketCap":44143323},{"date":"2024-10-18","current":-0.293964,"twenty":-3.869127,"median":-1.969927,"eighty":-0.501291,"marketCap":53221641},{"date":"2024-10-25","current":-0.265132,"twenty":-3.869127,"median":-1.940468,"eighty":-0.497971,"marketCap":48001608},{"date":"2024-10-31","current":-0.300232,"twenty":-3.869127,"median":-1.903391,"eighty":-0.491332,"marketCap":54356431},{"date":"2024-11-08","current":-0.316529,"twenty":-3.869283,"median":-1.882185,"eighty":-0.469421,"marketCap":57306884},{"date":"2024-11-15","current":-0.54413,"twenty":-3.869283,"median":-1.868211,"eighty":-0.465679,"marketCap":72456328},{"date":"2024-11-22","current":-0.458929,"twenty":-3.869283,"median":-1.842868,"eighty":-0.460768,"marketCap":61110947},{"date":"2024-11-29","current":-0.526622,"twenty":-3.869283,"median":-1.8322,"eighty":-0.460768,"marketCap":70124956},{"date":"2024-12-06","current":-0.541112,"twenty":-3.869283,"median":-1.817505,"eighty":-0.460768,"marketCap":72054472},{"date":"2024-12-13","current":-0.473635,"twenty":-3.869283,"median":-1.809882,"eighty":-0.460768,"marketCap":63069262},{"date":"2024-12-20","current":-0.429516,"twenty":-3.869283,"median":-1.800357,"eighty":-0.453636,"marketCap":57194317},{"date":"2024-12-27","current":-0.561442,"twenty":-3.869283,"median":-1.790831,"eighty":-0.453636,"marketCap":74761555},{"date":"2025-01-03","current":-0.612482,"twenty":-3.869283,"median":-1.788234,"eighty":-0.453636,"marketCap":81558060},{"date":"2025-01-10","current":-0.714994,"twenty":-3.869438,"median":-1.7794,"eighty":-0.453313,"marketCap":95208667},{"date":"2025-01-17","current":-0.338682,"twenty":-3.869438,"median":-1.766681,"eighty":-0.450075,"marketCap":45098842},{"date":"2025-01-24","current":-0.299753,"twenty":-3.869438,"median":-1.748466,"eighty":-0.442936,"marketCap":39915067},{"date":"2025-01-31","current":-0.367229,"twenty":-3.869438,"median":-1.739526,"eighty":-0.42444,"marketCap":48900277},{"date":"2025-02-07","current":-0.454603,"twenty":-3.869438,"median":-1.728187,"eighty":-0.402612,"marketCap":60534972},{"date":"2025-02-14","current":-0.377178,"twenty":-3.869438,"median":-1.713007,"eighty":-0.385236,"marketCap":50225020},{"date":"2025-02-21","current":-0.325273,"twenty":-3.869438,"median":-1.701707,"eighty":-0.369404,"marketCap":43313320},{"date":"2025-02-28","current":-0.298023,"twenty":-3.869438,"median":-1.680233,"eighty":-0.364729,"marketCap":39684677},{"date":"2025-03-07","current":-0.29413,"twenty":-3.869594,"median":-1.658178,"eighty":-0.355551,"marketCap":39166300},{"date":"2025-03-14","current":-0.462652,"twenty":-3.869594,"median":-1.648593,"eighty":-0.355551,"marketCap":39511885},{"date":"2025-03-21","current":-0.462385,"twenty":-3.869594,"median":-1.648593,"eighty":-0.355551,"marketCap":39489046},{"date":"2025-03-28","current":-0.471989,"twenty":-3.869594,"median":-1.635562,"eighty":-0.355551,"marketCap":40309293},{"date":"2025-04-04","current":-0.40613,"twenty":-3.869594,"median":-1.611748,"eighty":-0.355551,"marketCap":34684741},{"date":"2025-04-11","current":-0.363596,"twenty":-3.869438,"median":-1.610347,"eighty":-0.356068,"marketCap":31052217},{"date":"2025-04-17","current":-0.400642,"twenty":-3.869438,"median":-1.6046,"eighty":-0.356068,"marketCap":34216028},{"date":"2025-04-25","current":-0.521383,"twenty":-3.869594,"median":-1.589311,"eighty":-0.355551,"marketCap":44527708},{"date":"2025-05-02","current":-0.518639,"twenty":-3.869594,"median":-1.56828,"eighty":-0.355551,"marketCap":44293352},{"date":"2025-05-09","current":-0.509035,"twenty":-3.869594,"median":-1.535542,"eighty":-0.355551,"marketCap":43473104},{"date":"2025-05-16","current":-2.850604,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":44586297},{"date":"2025-05-23","current":-2.663311,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":41656842},{"date":"2025-05-30","current":-2.972882,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":46498849},{"date":"2025-06-06","current":-3.209188,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":50194912},{"date":"2025-06-13","current":-3.319718,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":51923715},{"date":"2025-06-20","current":-3.056733,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":47810355},{"date":"2025-06-27","current":-3.030053,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":47393058},{"date":"2025-07-03","current":-3.226339,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":50463174},{"date":"2025-07-11","current":-3.613195,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":56513986},{"date":"2025-07-18","current":-4.218755,"twenty":-3.877794,"median":-1.520301,"eighty":-0.355331,"marketCap":65985547},{"date":"2025-07-25","current":-5.313633,"twenty":-3.899391,"median":-1.520301,"eighty":-0.355331,"marketCap":83110530},{"date":"2025-08-01","current":-5.005155,"twenty":-3.921063,"median":-1.520301,"eighty":-0.355331,"marketCap":78285634},{"date":"2025-08-08","current":-4.761849,"twenty":-3.930868,"median":-1.520301,"eighty":-0.355331,"marketCap":74480082},{"date":"2025-08-15","current":13.743703,"twenty":-3.937459,"median":-1.513558,"eighty":-0.349195,"marketCap":79644760},{"date":"2025-08-22","current":13.925963,"twenty":-3.937459,"median":-1.493765,"eighty":-0.33554,"marketCap":80700957},{"date":"2025-08-29","current":14.980409,"twenty":-3.937459,"median":-1.482245,"eighty":-0.323584,"marketCap":86811473},{"date":"2025-09-05","current":15.513693,"twenty":-3.937759,"median":-1.459183,"eighty":-0.318266,"marketCap":89901849},{"date":"2025-09-12","current":14.738008,"twenty":-3.937459,"median":-1.447906,"eighty":-0.314998,"marketCap":85406757},{"date":"2025-09-19","current":14.628927,"twenty":-3.937459,"median":-1.414789,"eighty":-0.31238,"marketCap":84774634},{"date":"2025-09-26","current":16.76206,"twenty":-3.937459,"median":-1.390765,"eighty":-0.309994,"marketCap":97136139},{"date":"2025-10-03","current":17.549865,"twenty":-3.937459,"median":-1.383131,"eighty":-0.307239,"marketCap":101701467},{"date":"2025-10-10","current":19.489076,"twenty":-3.937459,"median":-1.377418,"eighty":-0.301349,"marketCap":112939198},{"date":"2025-10-17","current":18.47705,"twenty":-3.937459,"median":-1.367045,"eighty":-0.299621,"marketCap":107074507},{"date":"2025-10-24","current":17.113542,"twenty":-3.937459,"median":-1.347845,"eighty":-0.298408,"marketCap":99172977},{"date":"2025-10-31","current":17.022642,"twenty":-3.937459,"median":-1.334707,"eighty":-0.294531,"marketCap":98646209},{"date":"2025-11-07","current":14.325926,"twenty":-3.937459,"median":-1.310945,"eighty":-0.293494,"marketCap":83018739},{"date":"2025-11-14","current":16.228777,"twenty":-3.924842,"median":-1.291996,"eighty":-0.290418,"marketCap":94045762},{"date":"2025-11-21","current":4.073301,"twenty":-3.917793,"median":-1.286405,"eighty":-0.287842,"marketCap":95319306},{"date":"2025-11-28","current":4.65256,"twenty":-3.879809,"median":-1.268927,"eighty":-0.283616,"marketCap":108874548},{"date":"2025-12-05","current":4.375255,"twenty":-3.872631,"median":-1.259524,"eighty":-0.279619,"marketCap":102385337},{"date":"2025-12-12","current":5.490637,"twenty":-3.85552,"median":-1.247919,"eighty":-0.274466,"marketCap":128486387},{"date":"2025-12-19","current":5.308848,"twenty":-3.835294,"median":-1.218506,"eighty":-0.271366,"marketCap":124232349},{"date":"2025-12-26","current":5.41977,"twenty":-3.796749,"median":-1.205901,"eighty":-0.270453,"marketCap":126828033},{"date":"2026-01-02","current":5.573828,"twenty":-3.777378,"median":-1.201699,"eighty":-0.267335,"marketCap":130433151},{"date":"2026-01-09","current":5.373552,"twenty":-3.755066,"median":-1.172402,"eighty":-0.263816,"marketCap":125746498},{"date":"2026-01-16","current":1.423498,"twenty":-3.720766,"median":-1.148164,"eighty":-0.258521,"marketCap":33311285},{"date":"2026-01-23","current":1.540583,"twenty":-3.694267,"median":-1.142775,"eighty":-0.255292,"marketCap":36051175},{"date":"2026-01-30","current":1.697722,"twenty":-3.678422,"median":-1.091985,"eighty":-0.252428,"marketCap":39728394},{"date":"2026-02-06","current":1.389606,"twenty":-3.646567,"median":-1.038402,"eighty":-0.248146,"marketCap":32518159},{"date":"2026-02-13","current":1.371119,"twenty":-3.617614,"median":-1.002656,"eighty":-0.245698,"marketCap":32085545}],"updateTime":1771072939995},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604322531","title":"Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2604322531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604322531?lang=en_us&edition=fundamental","pubTime":"2026-01-20 00:30","pubTimestamp":1768840215,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc ($ATRA) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 study, officially titled “Multice...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tabelecleucels-phase-3-ebv-ptld-trial-progress-signals-continued-potential-for-atara-biotherapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tabelecleucels-phase-3-ebv-ptld-trial-progress-signals-continued-potential-for-atara-biotherapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4139","LU2065732104.USD","BK4097","ATRA"],"gpt_icon":0},{"id":"2603621292","title":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2603621292","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603621292?lang=en_us&edition=fundamental","pubTime":"2026-01-15 10:16","pubTimestamp":1768443414,"startTime":"0","endTime":"0","summary":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc               Panacea Innovation Ltd, a beneficial owner of Atara Biotherapeutics Inc., has reported a disposal of common...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL5qQkCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2603649942","title":"Atara's Outlook As Ebvallo Hits Second FDA CRL","url":"https://stock-news.laohu8.com/highlight/detail?id=2603649942","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603649942?lang=en_us&edition=fundamental","pubTime":"2026-01-15 02:28","pubTimestamp":1768415280,"startTime":"0","endTime":"0","summary":"The BLA is primarily supported by data from the Phase 3, single-arm, open-label ALLELE trial . In the ALLELE trial, Ebvallo met its prespecified primary efficacy endpoint and demonstrated a generally tolerable safety profile.It is noteworthy that Ebvallo had already received European Commission marketing authorization in the EU on 16 December 2022.In the U.S., Ebvallo previously received a CRL on January 15, 2025, which identified a single manufacturing compliance deficiency and did not raise concerns regarding safety, efficacy, or trial design.On January 9, 2026, Atara received a second FDA Complete Response Letter  for the Biologics License Application  for Ebvallo.Atara is currently at an extremely constrained net liquidity level. However, Atara has already monetized a portion of its Ebvallo EU royalty and certain milestone economics through the HCRx royalty-interest transaction. As Ebvallo has now been rejected by the FDA, the company may have very few remaining unencumbered assets","market":"sh","thumbnail":"/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/26/01/49916695/atara-outlook-as-ebvallo-hits-second-fda-crl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/26/01/49916695/atara-outlook-as-ebvallo-hits-second-fda-crl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4530","ATRA","BK4139","CRL","LU0029874061.USD","LU1815336091.USD","LU0128526141.USD","BK4588","LU0757428866.USD","IE00BFMHRM44.USD","LU0390134368.USD","BK4585","BK4121"],"gpt_icon":0},{"id":"2603463034","title":"Atara Biotherapeutics Cut to Hold From Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2603463034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603463034?lang=en_us&edition=fundamental","pubTime":"2026-01-14 04:28","pubTimestamp":1768336080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 15:28 ET (20:28 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2603689582","title":"Canaccord Genuity Downgrades Atara Biotherapeutics to Hold From Buy, Adjusts PT to $6 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689582","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689582?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:20","pubTimestamp":1768306859,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc (ATRA) has an average rating of Buy and mean price target of $19.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JF","ATRA","PT"],"gpt_icon":0},{"id":"2603521525","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521525","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603521525?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:18","pubTimestamp":1768249083,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics (ATRA) said Monday the US Food and Drug Administration is \"unable\" to approve its biologics license application for EBVALLO as a monotherapy treatment for the Epstein-Barr virus-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4166","BK4139","BK4561","LYRA","BK4588","LU1861217088.USD","LU1861220207.SGD","SYF","LU0106831901.USD","LU1668664300.SGD","LU1791807156.HKD","BK4585","LU2360107671.USD","BK4007","ATRA"],"gpt_icon":0},{"id":"2602241541","title":"BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2602241541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602241541?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:40","pubTimestamp":1768232404,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver minersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL6N3YD0S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APH","WMT","BAC","WBD","ZYME","HL","JILL","CAT","FERG","AEO","SLNO","AFRM","OMF","AGCO","SCCO","AKAM","ABNB","CRH","EPD","BIRK","CDE","ALB","SHAK","CMI","URI","XYZ","MRNA","LYRA","SLM","SYF","JBHT","SEZL","URBN","ATRA","SNCY","KLAR","SRRK","ANF","MDLN","VG","NEM","CRWD","AWK","JCAP","QXO"],"gpt_icon":1},{"id":"2602541681","title":"Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541681","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602541681?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:24","pubTimestamp":1768231440,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics shares fell Monday after the company said the U.S. health regulator didn't approve its therapy, backtracking on its previous guidance.The biotech company on Monday said the Food and Drug Administration issued a complete response letter that refused to approve Ebvallo in its current form, with the regulator saying a previous trial is no longer considered to provide adequate evidence of effectiveness for accelerated approval.Atara said the decision is a departure from the FDA's prior stance, which had identified only one deficiency regarding manufacturing issues that Atara has since resolved.The company also said the FDA hadn't previously raised any new safety concerns, whereas the regulator now said the trial's design and analysis limit its interpretability.Atara said its partner, Pierre Fabre Pharmaceuticals, intends to request a type A meeting with the FDA, and said it expects the request to be granted within 45 days. Pierre Fabre and Atara plan to interact with ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602543608","title":"Atara Biotherapeutics Shares Plunge 55% Premarket After US FDA Declines to Approve Co's Blood Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543608?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:55","pubTimestamp":1768226154,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2602548756","title":"FDA says unable to approve Atara Biotherapeutics Ebvallo BLA in present form","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548756","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548756?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:37","pubTimestamp":1768225066,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics (ATRA) announced that the FDA has issued a complete response letter, or CRL, for the Ebvallo biologics license application as...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-says-unable-to-approve-atara-biotherapeutics-ebvallo-bla-in-present-form-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-says-unable-to-approve-atara-biotherapeutics-ebvallo-bla-in-present-form-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2602483615","title":"BUZZ-Atara Biotherapeutics sinks as FDA rejects cancer drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2602483615","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602483615?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:22","pubTimestamp":1768224141,"startTime":"0","endTime":"0","summary":"BUZZ-Atara Biotherapeutics sinks as FDA rejects cancer drug application** Shares of drugmaker Atara Biotherapeutics ATRA.O fall 49% to $6.91 premarket** Co says U.S. FDA has rejected its application to market Ebvallo, a treatment for a rare and aggressive cancer linked to the Epstein-Barr virus in patients who have received organ transplants** FDA said main trial was insufficient to prove effectiveness; had earlier indicated single-arm trial was acceptable - ATRA** No safety or manufacturing concerns raised, co says; plans meeting with FDA to discuss next steps** Epstein-Barr virus is a common virus that can cause infections and, in rare cases, lead to certain cancers** As of last close, stock up ~36% over the past year  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL4N3YD0YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602510421","title":"BRIEF-Pierre Fabre Pharmaceuticals On Jan 9, Got Complete Response Letter For Tabelecleucel BLA From U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510421","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510421?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:13","pubTimestamp":1768223596,"startTime":"0","endTime":"0","summary":"BRIEF-Pierre Fabre Pharmaceuticals On Jan 9, Got Complete Response Letter For Tabelecleucel BLA From U.S. FDAJan 12 (Reuters) - Atara Biotherapeutics Inc ATRA.O:PIERRE FABRE PHARMACEUTICALS: ON JAN 9,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602510172","title":"Pierre Fabre: in New Crl, FDA Said It No Longer Considers Previously Accepted Single-Arm Allele Study to Be Enough to Support Accelerated Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510172?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:10","pubTimestamp":1768223430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD167:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602965510","title":"US FDA declines to approve Atara's therapy for rare blood cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602965510","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602965510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:06","pubTimestamp":1768223190,"startTime":"0","endTime":"0","summary":"US FDA declines to approve Atara's therapy for rare blood cancer Jan 12  - The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' ATRA.O cell therapy for a rare form of blood cancer, the company said.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL4N3YD0XP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2602510951","title":"BRIEF-Atara Biotherapeutics Provides Regulatory And Business Update On Ebvallo™ (Tabelecleucel)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510951","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510951?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223116,"startTime":"0","endTime":"0","summary":"BRIEF-Atara Biotherapeutics Provides Regulatory And Business Update On Ebvallo (Tabelecleucel)Jan 12 (Reuters) - Atara Biotherapeutics Inc ATRA.O:ATARA BIOTHERAPEUTICS PROVIDES REGULATORY AND BUSINESS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA99RDBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602510342","title":"Atara Biotherapeutics Slashes Workforce by 90 Percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510342","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510342?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:03","pubTimestamp":1768223020,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc. has implemented significant operational efficiencies in 2025, including an approximately 90% reduction in headcount year over year. The company also transitioned substantially all tab-cel activities and associated costs, including regulatory, clinical, and CMC responsibilities, to Pierre Fabre Laboratories. These changes are part of Atara's broader efforts to streamline operations and manage costs amid ongoing regulatory developments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeutics Inc. published the original content used to generate this news brief via Business Wire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLb0hTxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Atara Biotherapeutics Slashes Workforce by 90 Percent","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602551033","title":"Atara Biotherapeutics Inc - FDA Unable to Approve Ebvallo Bla in Present Form","url":"https://stock-news.laohu8.com/highlight/detail?id=2602551033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602551033?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA99RDBT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2602510370","title":"Atara Biotherapeutics Inc - FDA Issues Complete Response Letter for Ebvallo Bla","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510370?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA99RDBT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602358510","title":"Atara Biotherapeutics Inc: U.S. Food and Drug Administration Has Issued a Complete Response Letter (Crl)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602358510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602358510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA99RDBT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2602051517","title":"Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo™ (Tabelecleucel)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602051517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602051517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA99RDBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}